Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting

[Image: see text]

Detalles Bibliográficos
Autores principales: Papp, K.A., Gooderham, M.J., Albrecht, L.E., Raymond, M.‐A., Lynde, C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374060/
https://www.ncbi.nlm.nih.gov/pubmed/34748637
http://dx.doi.org/10.1111/bjd.20885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374060/
https://www.ncbi.nlm.nih.gov/pubmed/34748637
http://dx.doi.org/10.1111/bjd.20885

Ejemplares similares